BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 22815482)

  • 21. Accelerated disassembly of IgE-receptor complexes by a disruptive macromolecular inhibitor.
    Kim B; Eggel A; Tarchevskaya SS; Vogel M; Prinz H; Jardetzky TS
    Nature; 2012 Nov; 491(7425):613-7. PubMed ID: 23103871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid polyclonal desensitization with antibodies to IgE and FcεRIα.
    Khodoun MV; Kucuk ZY; Strait RT; Krishnamurthy D; Janek K; Lewkowich I; Morris SC; Finkelman FD
    J Allergy Clin Immunol; 2013 Jun; 131(6):1555-64. PubMed ID: 23632296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The importance of Lys-352 of human immunoglobulin E in FcepsilonRII/CD23 recognition.
    Sayers I; Housden JE; Spivey AC; Helm BA
    J Biol Chem; 2004 Aug; 279(34):35320-5. PubMed ID: 15199058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SLAP Is a Negative Regulator of FcεRI Receptor-Mediated Signaling and Allergic Response.
    Sharma N; Ponce M; Kaul S; Pan Z; Berry DM; Eiwegger T; McGlade CJ
    Front Immunol; 2019; 10():1020. PubMed ID: 31156621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulation of FcepsilonRI on human basophils by IgE antibody is mediated by interaction of IgE with FcepsilonRI.
    MacGlashan D; Lichtenstein LM; McKenzie-White J; Chichester K; Henry AJ; Sutton BJ; Gould HJ
    J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 1):492-8. PubMed ID: 10452777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IgE, mast cells, basophils, and eosinophils.
    Stone KD; Prussin C; Metcalfe DD
    J Allergy Clin Immunol; 2010 Feb; 125(2 Suppl 2):S73-80. PubMed ID: 20176269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IgE binds asymmetrically to its B cell receptor CD23.
    Dhaliwal B; Pang MO; Keeble AH; James LK; Gould HJ; McDonnell JM; Sutton BJ; Beavil AJ
    Sci Rep; 2017 Mar; 7():45533. PubMed ID: 28361904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temperature effect on IgE binding to CD23 versus Fc epsilon RI.
    Chen BH; Kilmon MA; Ma C; Caven TH; Chan-Li Y; Shelburne AE; Tombes RM; Roush E; Conrad DH
    J Immunol; 2003 Feb; 170(4):1839-45. PubMed ID: 12574349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigen-induced reduction in mast cell and basophil functional responses due to reduced Syk protein levels.
    Kepley CL
    Int Arch Allergy Immunol; 2005 Sep; 138(1):29-39. PubMed ID: 16088210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparable actions of omalizumab on mast cells and basophils.
    Serrano-Candelas E; Martinez-Aranguren R; Valero A; Bartra J; Gastaminza G; Goikoetxea MJ; Martín M; Ferrer M
    Clin Exp Allergy; 2016 Jan; 46(1):92-102. PubMed ID: 26509363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FcεRI expression and IgE binding by dendritic cells and basophils in allergic rhinitis and upon allergen immunotherapy.
    Berings M; Gevaert P; De Ruyck N; Derycke L; Holtappels G; Pilette C; Bachert C; Lambrecht BN; Dullaers M
    Clin Exp Allergy; 2018 Aug; 48(8):970-980. PubMed ID: 29682789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of antigen-induced mediator release from IgE-sensitized cells by a monoclonal anti-Fc epsilon RI alpha-chain receptor antibody: implications for the involvement of the membrane-proximal alpha-chain region in Fc epsilon RI-mediated cell activation.
    Nechansky A; Robertson MW; Albrecht BA; Apgar JR; Kricek F
    J Immunol; 2001 May; 166(10):5979-90. PubMed ID: 11342613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Requirements for effective IgE cross-linking on mast cells and basophils.
    Knol EF
    Mol Nutr Food Res; 2006 Jul; 50(7):620-4. PubMed ID: 16764017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural and Physical Basis for Anti-IgE Therapy.
    Wright JD; Chu HM; Huang CH; Ma C; Chang TW; Lim C
    Sci Rep; 2015 Jun; 5():11581. PubMed ID: 26113483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Necessity of the stalk region for immunoglobulin E interaction with CD23.
    Chen BH; Ma C; Caven TH; Chan-Li Y; Beavil A; Beavil R; Gould H; Conrad DH
    Immunology; 2002 Nov; 107(3):373-81. PubMed ID: 12423314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beyond immediate hypersensitivity: evolving roles for IgE antibodies in immune homeostasis and allergic diseases.
    Burton OT; Oettgen HC
    Immunol Rev; 2011 Jul; 242(1):128-43. PubMed ID: 21682742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-affinity IgE receptor (FcepsilonRII)-mediated activation of human monocytes by both monomeric IgE and IgE/anti-IgE immune complex.
    Ezeamuzie CI; Al-Attiyah R; Shihab PK; Al-Radwan R
    Int Immunopharmacol; 2009 Aug; 9(9):1110-4. PubMed ID: 19505590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effector roles of IgE antibodies: targeting allergen to the high-affinity IgE receptor for Fc epsilon RI-dependent signaling and antigen presentation.
    Wilson BS; Oliver JM
    Clin Allergy Immunol; 2002; 16():197-232. PubMed ID: 11577540
    [No Abstract]   [Full Text] [Related]  

  • 39. Suppression of mast cell degranulation through a dual-targeting tandem IgE-IgG Fc domain biologic engineered to bind with high affinity to FcγRIIb.
    Cemerski S; Chu SY; Moore GL; Muchhal US; Desjarlais JR; Szymkowski DE
    Immunol Lett; 2012 Mar; 143(1):34-43. PubMed ID: 22305932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human mast cell line-1 (HMC-1) cells transfected with FcεRIα are sensitive to IgE/antigen-mediated stimulation demonstrating selectivity towards cytokine production.
    Xia YC; Sun S; Kuek LE; Lopata AL; Hulett MD; Mackay GA
    Int Immunopharmacol; 2011 Aug; 11(8):1002-11. PubMed ID: 21356342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.